Chimeric hepatitis E virus-like particle as a carrier for oral-delivery

Highlights ► Sequence insertion at antigenic domain of HEV-VLP does not interfere with icosahedral assembly. ► Sequence insertion induces conformational changes at HEV antigenic domain leading to deterioration in antibody-binding. ► Sequence insertion introduces a trypsin cleavage site in the recomb...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Vaccine 2013-01, Vol.31 (2), p.417-424
Hauptverfasser: Jariyapong, Pitchanee, Xing, Li, van Houten, Nienke E, Li, Tian-Cheng, Weerachatyanukul, Wattana, Hsieh, Benjamin, Moscoso, Carlos G, Chen, Chun-Chieh, Niikura, Masahiro, Cheng, R. Holland
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Highlights ► Sequence insertion at antigenic domain of HEV-VLP does not interfere with icosahedral assembly. ► Sequence insertion induces conformational changes at HEV antigenic domain leading to deterioration in antibody-binding. ► Sequence insertion introduces a trypsin cleavage site in the recombinant HEV capsid protein. ► The chimeric VLP remains intact after trypsin cleavage.
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.10.073